TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapyChristopher B. Rodell, Ralph Weissleder, Sean P. Arlauckas et al.|Nature Biomedical Engineering|2018Cited by 1.1k
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Mikaël J. Pittet, Camilla Engblom et al.|Immunity|2016Cited by 954
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher Garris, Mikaël J. Pittet, Sean P. Arlauckas et al.|Immunity|2018Cited by 937
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapySean P. Arlauckas, Mikaël J. Pittet, Christopher Garris et al.|Science Translational Medicine|2017Cited by 654
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Mikaël J. Pittet, Nicolas A. Gort-Freitas et al.|Cell|2023Cited by 393